UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): July 18, 2005

 

QUIDEL CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

 

0-10961

 

94-2573850

(State or Other Jurisdiction
of Incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

10165 McKellar Court
San Diego, California

 

92121

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:    (858) 552-1100

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 1.01                                             Entry into a Material Definitive Agreement.

 

On July 18, 2005, Quidel Corporation (the “Company”) entered into an amendment (the “First Amendment”) to its Credit Agreement, dated as of January 31, 2005, by and among the Company, certain lenders from time to time a party thereto and Bank of America, N.A., as agent and l/c issuer (the “Credit Agreement”).  The Company entered into the First Amendment to amend certain commercial bank loan covenants and definitions in the Credit Agreement because of the Company’s up-front payment obligation in connection with the patent litigation settlement between the Company and Inverness Medical Innovations, Inc.   A copy of the First Amendment to the Credit Agreement is attached as Exhibit 10.1 hereto and is incorporated herein by reference.  The First Amendment to the Credit Agreement is dated as of June 24, 2005.

 

Item 9.01                                             Financial Statements and Exhibits.

 

(c)                                  Exhibits:

 

The following exhibit is filed with this current report on Form 8-K:

 

Exhibit Number

 

Description of Exhibit

 

 

 

10.1

 

First Amendment to Credit Agreement, dated as of June 24, 2005, by and among Quidel Corporation, as Borrower, certain subsidiaries of the Company, each lender from time to time a party thereto and Bank of America, N.A., as Agent and L/C Issuer.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     Date:  July 19, 2005

 

 

QUIDEL CORPORATION

 

 

 

 

 

By:

/s/ Paul E. Landers

 

 

Name:

Paul E. Landers

 

Its:

Senior Vice President, Chief Financial Officer

 

 

and Secretary

 

3



 

EXHIBIT INDEX

 

Exhibit Number

 

Description of Exhibit

 

 

 

10.1

 

First Amendment to Credit Agreement, dated as of June 24, 2005, by and among Quidel Corporation, as Borrower, certain subsidiaries of the Company, each lender from time to time a party thereto and Bank of America, N.A., as Agent and L/C Issuer.

 

4